当前位置:
X-MOL 学术
›
Clin. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST-segment elevation myocardial infarction
Clinical Cardiology ( IF 2.7 ) Pub Date : 2021-08-18 , DOI: 10.1002/clc.23716 Robert C Welsh 1, 2, 3 , Jay S Shavadia 1, 4 , Yinggan Zheng 1, 2, 3 , Benjamin D Tyrrell 5 , Raymond Leung 5 , Kevin R Bainey 1, 2, 3
Clinical Cardiology ( IF 2.7 ) Pub Date : 2021-08-18 , DOI: 10.1002/clc.23716 Robert C Welsh 1, 2, 3 , Jay S Shavadia 1, 4 , Yinggan Zheng 1, 2, 3 , Benjamin D Tyrrell 5 , Raymond Leung 5 , Kevin R Bainey 1, 2, 3
Affiliation
To describe and evaluate outcomes in STEMI patients sustained on clopidogrel compared to those switched to ticagrelor following fibrinolysis.
中文翻译:
替格瑞洛或氯吡格雷双重抗血小板治疗在 ST 段抬高型心肌梗死的药物侵入策略后
描述和评估持续使用氯吡格雷的 STEMI 患者与纤溶后改用替格瑞洛的患者的结果。
更新日期:2021-08-18
中文翻译:
替格瑞洛或氯吡格雷双重抗血小板治疗在 ST 段抬高型心肌梗死的药物侵入策略后
描述和评估持续使用氯吡格雷的 STEMI 患者与纤溶后改用替格瑞洛的患者的结果。